Trial Profile
Efficacy of adalimumab and etanercept in patients with rheumatoid arthritis: a prognostic biomarker study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Feb 2016
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Etanercept (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics; Therapeutic Use
- 01 Feb 2016 New trial record